An appetite suppressant to help reduce calories while having positive effect on mood would be nice.
Check out Tesofensine!
"Tesofensine, a novel triple monoamine reuptake inhibitor, produces a significant weight loss in humans."
"...the [reduced eating over a prolonged period] effect of tesofensine was longer lasting than sibutramine and rimonabant."
"...only tesofensine significantly suppressed the plasma insulin response below the level that could be obtained by paired feeding, indicating that tesofensine further improved glycemic control. In conclusion, the robust weight loss with long-term tesofensine treatment is likely due to a combined synergistic effect of appetite suppression and increased energy expenditure."
(reference: The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant - PubMed)
TESOS – An Exciting NEW Fat-Loss Product from Pharmacom Labs! – is Now Available in the Basicstero Store.
This innovative Oral-Line Fat-Loss product is currently offered as a 50 count blister strip of 0.5 mg tablets (PRICE FOR 1 BLISTER, 50 PILLS).
Tesofensine Information:
Tesofensine is a unique new generation Triple Serotonin Norepinephrine Dopamine Reuptake Inhibitor (SNDRI).
SNDRI belong to the class of psychoactive antidepressants. They affect neurotransmitters in the brain, exactly serotonin, norepinephrine and dopamine. Tesofensin affects the brain qualitatively, helping a person to feel maximum saturation during eating, and reduce appetite significantly.
Tesofensin was originally developed and patented by NeuroSearch A/S (Denmark) to cure Parkinson's and Alzheimer's diseases.
• acts centrally, suppress appetite, regulate the availability of dopamine receptors and stimulate α1-adrenergic receptors.
• appetite decreases within 14 days, there is a higher level of satiety and less desire to eat.
• increases significantly fat oxidation and reduces adipose tissue.
• improves the level of insulin sensitivity, which leads to higher glucose metabolism.
• alters the expression of dopaminergic receptors in the striatum of the brain, as well as their binding.
• the energy consumption increases greatly within 14 days.
• The drug has a long half-life, which is 8-9 days, and metabolized mainly in the liver by CYP3A4 to the disalkyl metabolite M1 (NS-2360), which is the only metabolite found in human blood plasma.
Chemical name: (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
Formula: C17H23Cl2NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
ACTIVE HALF-LIFE: 9 days
CLASSIFICATION: psychoactive antidepressants.
DOSAGE: 0.25 mg -1 mg
ACNE: no
WATER RETENTION: no
HBR: Perhaps
HEPATOXITY: Low
AROMATIZATION: no
The Basicstero Team hopes this NEW Pharmacom Labs Fat-Loss product will help you reach your goals!
